| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
8e-05 |
| mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.0002 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.4 |
0.0002 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |